Kathryn Reed

Three Movers to Watch for: VCA Inc. (WOOF), Celsion Corporation (CLSN), HCP, Inc. (HCP)

VCA Inc. (WOOF) retreated with the stock falling -0.03% or $-0.03 to close at $90.95 on active trading volume of 3.04M compared its three months average trading volume of 1.62M. The Los Angeles California 90064 based company operating under the Personal Services industry has been trending up for the last 52 weeks, with the shares price now 101.35% up for the period and up by 32.48% so far this year. With price target of $76.01 and a 106.7% rebound from 52-week low, VCA Inc. has plenty of upside potential, making it a hold with a view buy.

VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates in two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services for companion animals, as well as specialized treatments comprising diagnostic, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology services; and sells related retail and pharmaceutical products. It also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. In addition, this segment performs various pet wellness programs, such as health examinations, diagnostic testing, routine vaccinations, spaying, neutering, and dental care. As of December 31, 2015, it operated or managed 682 animal hospitals. The Laboratory segment offers testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment, and prevention of diseases and other conditions affecting animals. This segment serves animal hospitals, animal practices, universities, and other government organizations. It operated a network of 60 laboratories. VCA Inc. also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market, as well as provides education and training, consulting, and mobile imaging services; and franchises pet services, including dog day care, overnight boarding, grooming, and other ancillary services at pet care facilities. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. VCA Inc. was founded in 1986 and is headquartered in Los Angeles, California.

Celsion Corporation (CLSN) dropped $-0.1 to close the day at a new closing price of $0.41, a -19.41% decrease in value from its previous closing price that moved the stock 41.72% above its 52 week low of $0.29. A total of 3.03M shares exchanged hands during the day compared with its three month average trading volume of 639.00K. The stock, which fluctuated between $0.411 and $0.55 during the day, currently situated -76.91% below its 52 week high. The stock is down by -19.43% in the past one month and down by -62.29% over the past three months. With a one year target estimate of $3.33 and RSI of 45.56, the stock still has upside potential, making it a hold for now.

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company’s lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. Ltd. for ThermoDox; and a commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. for the production of ThermoDox in mainland China, Hong Kong, and Macau. The company also has a collaboration with the Children’s Research Institute to conduct a clinical study of ThermoDox, a heat activated liposomal encapsulation of doxorubicin in combination with magnetic resonance-guided high intensity focused ultrasound to treat relapsed or refractory solid tumors in children and young adults. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

HCP, Inc. (HCP) shares were down in last trading by -0.42% to $30.55. It experienced lighter than average volume on day. The stock increased in value by almost 1.66% over the past week and grew 7.53% in the past month. It is currently trading 3.38% above its 50 day moving average and -3.17% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -16.01% decrease in value from its one year high of $36.82. The RSI indicator value of 55.45, lead us to believe that it is a hold for now.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry including sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing. The fund also invests in mezzanine loans and other debt instruments. It engages in acquisition, development, leasing, selling and managing of healthcare real estate and provides mortgage and other financing to healthcare providers. The fund benchmarks the performance of its portfolio against the S&P 500 Index, Berkshire Hathaway Index, and MSCI REIT Index. HCP, Inc. was formed in 1985 and is based in Irvine, California with additional office in Nashville and San Francisco.

 

Stocks in Review: Archer-Daniels-Midland Company (ADM), D.R. Horton, Inc. (DHI), Walgreens Boots Alliance, Inc. (WBA)

Archer-Daniels-Midland Company (ADM) traded within a range of $44.7 to $45.22 after opening the day at $44.74. The company has seen its stock decrease in value by -1.53% so far this year. The stock was up close to 0.58% on light volume in last trading session and closed at $44.95 per share. After the recent gain, the stock is currently holding -5.44% below its 52 week high of $47.88 and 55.3% above its 12-month low of $31.2. The shares are up by over 8.19% in the last three months, and the RSI indicator value of 51.05 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. Its Agricultural Services segment offers agricultural commodities, such as oilseeds, corn, wheat, milo, oats, rice, and barley; and resells those commodities as food and feed ingredients, and raw materials for the agricultural processing industry. The segment is also involved in structured trade finance and the processing of wheat into wheat flour. Its Corn Processing segment offers ingredients used in the food and beverage industry, including sweeteners, starch, syrup, glucose, and dextrose; bio products; alcohol, amino acids, and other food and animal feed ingredients; and ethyl alcohol for industrial use as ethanol or as beverage grade. This segment also offers corn gluten feed and meal, and distillers’ grains; vegetable oil and protein meal; formula feeds, and animal health and nutrition products; and citric acids and glycols for food and industrial products, as well as operates a sugarcane ethanol plant. The company’s Oilseeds Processing segment processes soybeans and soft seeds into vegetable oils and protein meals. It offers ingredients for the food, feed, energy, and industrial products industries; crude vegetable and salad oils; partially refined oils; oilseed protein meals; peanuts, tree nuts, and peanut-derived ingredients; cottonseed flour for the pharmaceutical industry; cotton cellulose pulp for the chemical, paper, and filter markets; and agricultural commodity raw materials. Its Wild Flavors and Specialty Ingredients segment offers natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products, edible beans, and other specialty food and feed ingredients. The company is also involved in futures commission and insurance activities. Archer-Daniels-Midland Company was founded in 1898 and is headquartered in Chicago, Illinois.

D.R. Horton, Inc. (DHI) failed to extend gains with the stock declining -0.25% or $-0.07 to close the day at $28.5 on light trading volume of 2.95M shares, compared to its three month average trading volume of 4.69M. The Fort Worth Texas 76102 based company has been outperforming the residential construction group over the past 52 weeks, with the stock gaining 7.08%, compared to the industry which has advanced 16.94% over the same period. With RSI of 55.12, the stock should still continue to rise and get closer to its one year target estimate of $33.7, making it a hold for now.

D.R. Horton, Inc. operates as a homebuilding company. It engages in the acquisition and development of land; and construction and sale of homes in 26 states and 78 markets in the United States under the names of D.R. Horton, America’s Builder, Express Homes, Emerald Homes, Regent Homes, Crown Communities, and Pacific Ridge Homes. The company constructs and sells single-family detached homes; and attached homes, such as town homes, duplexes, triplexes, and condominiums. It is also involved in the origination and sale of mortgages; and provision of title insurance policies, and examination and closing services. The company primarily serves title insurance agents, homebuyers, and homebuilding customers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Fort Worth, Texas.

Walgreens Boots Alliance, Inc. (WBA) dropped $-0.1 to close the day at a new closing price of $84.12, a -0.12% decrease in value from its previous closing price that moved the stock 19.84% above its 52 week low of $71.5. A total of 2.94M shares exchanged hands during the day compared with its three month average trading volume of 4.48M. The stock, which fluctuated between $83.63 and $84.4 during the day, currently situated -4.41% below its 52 week high. The stock is down by -1.87% in the past one month and up by 8.33% over the past three months. With a one year target estimate of $94.42 and RSI of 51.6, the stock still has upside potential, making it a hold for now.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services; and manages in-store clinics. As of August 31, 2016, this segment operated 8,175 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, toiletry, and other consumer products through its pharmacy-led health and beauty stores, as well as through boots.com. It is also involved in optical practice and related contract manufacturing operations. This segment operated 4,673 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 636 optical practices. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in France, the United Kingdom, Germany, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

 

Stocks in Review: Aramark (ARMK), Palatin Technologies, Inc. (PTN), Hess Corporation (HES)

Aramark (ARMK) traded within a range of $33.21 to $33.75 after opening the day at $33.72. The company has seen its stock decrease in value by -6.77% so far this year. The stock was down close to -0.6% on active volume in last trading session and closed at $33.3 per share. After the recent fall, the stock is currently holding -12.8% below its 52 week high of $38.3 and 15.07% above its 12-month low of $29.18. The shares are down by over -9.61% in the last three months, and the RSI indicator value of 30.35 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Aramark provides food, facilities, and uniform services to education, healthcare, business and industry, sports, leisure, and corrections clients in North America and internationally. It offers managed services include dining, catering, food service management, convenience-oriented retail operations, grounds and facilities maintenance, custodial, energy and construction management, and capital project management. The company also provides non-clinical support services, such as patient food and nutrition, and retail food services; and facilities services comprising clinical equipment maintenance, environmental, laundry and linen distribution, plant operations, strategic/technical, energy and supply chain management, purchasing, and central transportation. In addition, it offers on-site restaurants, catering, convenience stores, and executive dining services; beverage and vending services; and facility management services comprising housekeeping, plant operations and maintenance, energy management, laundry and linen, grounds keeping, landscaping, transportation, capital program management and commissioning, and other facility consulting services. Further, the company provides facility and business support services for mining and oil operations; and concessions, banquet and catering, retail and merchandise sales, recreational and lodging, and facility management services for sports, entertainment, and recreational facilities. Additionally, it offers correctional food, and food and facilities management services for parks; and operates commissaries, laundry facilities, and property rooms. It also rents, sells, cleans, maintains, and delivers uniform and career apparel, and other textile items; and provides other garments and work clothes, as well as ancillary items. The company was formerly known as ARAMARK Holdings Corporation and changed its name to Aramark in May 2014. Aramark was founded in 1959 and is based in Philadelphia, Pennsylvania.

Palatin Technologies, Inc. (PTN) managed to rebound with the stock climbing 5.7% or $0.02 to close the day at $0.45 on light trading volume of 2.62M shares, compared to its three month average trading volume of 3.06M. The Cranbury New Jersey 08512 based company has been underperforming the diagnostic substances group over the past 52 weeks, with the stock losing -12.6%, compared to the industry which has advanced 42.16% over the same period. With RSI of 41.7, the stock should still continue to rise and get closer to its one year target estimate of $5, making it a hold for now.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s principal product is Bremelanotide, an as needed subcutaneous injectable peptide melanocortin receptor agonist, which is in the Phase III clinical studies for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD). Its drug development programs also include Melanocortin receptor-4 (MC4r) peptides and small molecule agonists that are under the preclinical trials for the treatment of conditions responsive to MC4r activation, including female sexual dysfunction, HSDD, erectile dysfunction, obesity, and diabetes; and Melanocortin receptor-1 peptide agonists, which are under preclinical studies for the treatment of inflammatory and dermatologic disease indications, as well as other Melanocortin receptors. In addition, the company is involved in the development of natriuretic peptide receptor-specific programs, including PL-3994, a natriuretic peptide receptor-A, which is in Phase II clinical studies for treatment of heart failure, acute exacerbations of asthma, and refractory hypertension. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.

Hess Corporation (HES) dropped $-0.47 to close the day at a new closing price of $58.83, a -0.79% decrease in value from its previous closing price that moved the stock 84.94% above its 52 week low of $34.02. A total of 2.62M shares exchanged hands during the day compared with its three month average trading volume of 4.37M. The stock, which fluctuated between $58.39 and $59.42 during the day, currently situated -9.91% below its 52 week high. The stock is down by -6.14% in the past one month and up by 16.22% over the past three months. With a one year target estimate of $65.29 and RSI of 43.94, the stock still has upside potential, making it a hold for now.

Hess Corporation, an exploration and production company, develops, produces, purchases, transports, and sells crude oil, natural gas liquids, and natural gas. The company operates in two segments, Exploration and Production, and Bakken Midstream. It is also involved in crude oil and natural gas gathering, processing of natural gas and the fractionation of natural gas liquids, transportation of crude oil by rail car, terminating and loading crude oil and natural gas liquids, and the storage and terminating of propane primarily in the Bakken shale play of North Dakota. The company operates primarily in the United States, Denmark, Equatorial Guinea, the Joint Development Area of Malaysia/Thailand, Malaysia, and Norway. As of December 31, 2015, it had total proved reserves of 1,086 million barrels of oil equivalent. The company was founded in 1920 and is headquartered in New York, New York.

 

Stocks Intraday Alert: News Corporation (NWSA), GoPro, Inc. (GPRO), Immunomedics, Inc. (IMMU)

News Corporation (NWSA) failed to extend gains with the stock declining -0.74% or $-0.09 to close the day at $12.14 on lower than average trading volume of 2.31M shares, compared to its three month average trading volume of 2.73M. The New York New York 10036 based company has been outperforming the broadcasting – tv companies by -9.2931% for last three months and its recent losses have trimmed gains to 5.93% YTD, versus the broadcasting – tv industry which is down -0.83% for the same period. The RSI of 59.17 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

News Corporation, a media and information services company, focuses on creating and distributing content to consumers and businesses worldwide. The company distributes content and data products, such as The Wall Street Journal, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, Barron’s, MarketWatch, Dow Jones Private Markets, and DJX through various media channels, including newspapers, newswires, Websites, newsletters, magazines, proprietary databases, conferences, and video, as well as applications for mobile devices, tablets, and electronic readers. It also owns and operates daily, Sunday, weekly, and bi-weekly newspapers, including The Australian, The Weekend Australian, The Daily Telegraph, The Sunday Telegraph, Herald Sun, Sunday Herald Sun, The Courier Mail, The Sunday Mail, The Advertiser, Sunday Mail, The Sun, The Sun on Sunday, The Times, The Sunday Times, and New York Post, as well as digital mastheads and other Websites. In addition, the company provides home-delivered shopper media, such as free-standing inserts and direct mail products; in-store marketing products and services primarily to consumer packaged goods manufacturers; in-store merchandising services; and digital marketing solutions. Further, it publishes general fiction, nonfiction, children’s, and religious books; and offers sports programming services with seven television channels distributed through cable, satellite and IP, various interactive viewing applications, and broadcast rights to live sporting events. Additionally, the company provides digital advertising services for property and property-related services on Websites and mobile applications; online real estate services; and professional software and services products, including Top Producer, TigerLead, and ListHub, as well as operates residential and commercial property Websites. News Corporation is headquartered in New York, New York.

GoPro, Inc. (GPRO) had a light trading with around 2.31M shares changing hands compared to its three month average trading volume of 4.62M. The stock traded at the price of $9.22 with -2.12% change on the day. The San Mateo California 94402 based company is currently trading 7.96% above its 52 week low of $8.54 and -47.85% below its 52 week high of $17.68. Both the RSI indicator and target price of 51.08 and $9.71 respectively, lead us to believe that it should be put on hold over the coming weeks.

GoPro, Inc. develops and sells mountable and wearable cameras, and accessories in the United States and internationally. The company offers HERO line of capture devices, such as cameras; and mounts comprising equipment-based mounts consisting of helmet, handlebar, roll bar, and grip and tripod mounts that enable consumers to capture content while engaged in a range of activities, as well as mounts that enable customers to wear the mount on their bodies, such as wrist housings, chest harnesses, and head straps. It also provides LCD Touch BacPac, Battery BacPac, Smart Remote, and Floaty Backdoor accessories, as well as spare batteries, charging accessories, cables to connect its GoPro cameras to television monitors, video transmitters and external microphones, flotation devices, dive filters, and anti-fogging solutions. In addition, the company offers GoPro Studio, a video editing tool that allows users to create professional quality videos from their content; and GoPro App that allows users to control GoPro cameras remotely using a smartphone or tablet. GoPro, Inc. markets and sells its products through retailers and distributors, as well as through its Website. The company was formerly known as Woodman Labs, Inc. and changed its name to GoPro, Inc. in February 2014. GoPro, Inc. was founded in 2004 and is headquartered in San Mateo, California.

Immunomedics, Inc. (IMMU) opening the day at $3.92. The company has seen its stock increase in value by 13.62% so far this year. The stock was up close to 7.2% on active volume in last trading session and closed at $4.17 per share. After the recent gain, the stock is currently holding -23.35% below its 52 week high of $5.44 and 159.01% above its 12-month low of $1.61. The shares are up by over 87.84% in the last three months, and the RSI indicator value of 66.53 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and epratuzumab, a humanized antibody that targets CD22, an antigen found on the surface of B lymphocytes. Its early-stage products include IMMU-114, a novel humanized antibody for the treatment of patients with B-cell and other cancers; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is present on various hematological tumors and solid cancers; Veltuzumab, a humanized monoclonal antibody targeting CD20 receptors on B lymphocytes for the treatment of non-Hodgkin lymphoma and autoimmune diseases; and Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.

 

Stocks on Trader’s Radar: Hovnanian Enterprises, Inc. (HOV), International Paper Company (IP), PPL Corporation (PPL)

Hovnanian Enterprises, Inc. (HOV) managed to rebound with the stock climbing 4.17% or $0.09 to close the day at $2.25 on active trading volume of 2.23M shares, compared to its three month average trading volume of 1.91M. The Red Bank New Jersey 07701 based company has been outperforming the residential construction group over the past 52 weeks, with the stock gaining 65.44%, compared to the industry which has advanced 16.94% over the same period. With RSI of 38.33, the stock should still continue to rise and get closer to its one year target estimate of $1.78, making it a hold for now.

Hovnanian Enterprises, Inc. designs, constructs, markets, and sells residential homes in the United States. It constructs single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes. The company markets its build homes for first-time buyers, first-time and second-time move-up buyers, luxury buyers, active lifestyle buyers, and empty nesters in 167 communities in 33 markets. It also provides financial services comprising originating mortgages from homebuyers and selling such mortgages in the secondary market, as well as offers title insurance services. The company was founded in 1959 and is headquartered in Red Bank, New Jersey.

International Paper Company (IP) climbed 0.08% during last trading as the stock added $0.04 to finish the day at $53.03 with about 2.22M shares changing hands, compared to its three month average trading volume of 2.63M. The $21.86B market cap company, which fluctuated between $52.66 and $53.2 during the day, currently situated 70.35% above its 52 week low of $32.5 and -3.02% away from its one year high of $54.68. The RSI of 51.99 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

International Paper Company operates as a paper and packaging company in North America, Europe, Latin America, Russia, Asia, Africa, and the Middle East. The company operates through three segments: Industrial Packaging, Printing Papers, and Consumer Packaging. The Industrial Packaging segment manufactures containerboards, including linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft. The Printing Papers segment produces printing and writing papers, such as uncoated papers for end use applications, including brochures, pamphlets, greeting cards, books, annual reports, and direct mail, as well as envelopes, tablets, business forms, and file folders. This segment sells uncoated papers under the Hammermill, Springhill, Williamsburg, Postmark, Accent, Great White, Chamex, Ballet, Rey, Pol, and Svetocopy brand names. It also produces pulp for manufacturing printing, writing, and specialty papers, as well as towels and tissues, filtration products, diapers, and sanitary napkins. The Consumer Packaging segment offers coated paperboards for various packaging and foodservice end uses, such as food, cosmetics, pharmaceuticals, and tobacco products under the Everest, Fortress, and Starcote brand names. This segment also produces cups, lids, food containers, and plates. The company sells its packaging products, paper products, and other products directly to end users and converters, as well as through agents, resellers, and paper distributors. International Paper Company was founded in 1898 and is headquartered in Memphis, Tennessee.

PPL Corporation (PPL) saw its value decrease by -0.43% as the stock dropped $-0.15 to finish the day at a closing price of $34.54. The stock was lighter in trading and has fluctuated between $32.08-$39.92 per share for the past year. The shares, which traded within a range of $34.48 to $34.74 during the day, are up by 5.69% in the past three months and down by -4.97% over the past six months. It is currently trading 0.67% above its 20 day moving average and 2.65% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $36.27 a share over the next twelve months. The current relative strength index (RSI) reading is 57.95. The technical indicator lead us to believe there will be no major movement any time soon, hold.

PPL Corporation, a utility company, delivers electricity and natural gas in the United States and the United Kingdom. It serves 322,000 natural gas and 403,000 electric customers in Louisville and adjacent areas in Kentucky; 543,000 customers in central, southeastern, and western Kentucky; and approximately 28,000 customers in 5 counties in southwestern Virginia, and fewer than 10 customers in Tennessee. The company also provides electric delivery services to approximately 1.4 million customers in Pennsylvania; and operates 4 electricity distribution networks in the United Kingdom, as well as delivers natural gas to customers in Kentucky; generates electricity from power plants in Kentucky; and sells wholesale electricity to 11 municipalities in Kentucky. In addition, it provides finance for the operations of PPL and subsidiaries. PPL Corporation was founded in 1920 and is headquartered in Allentown, Pennsylvania.

 

Stocks Under Consideration: Northern Trust Corporation (NTRS), Neurocrine Biosciences, Inc. (NBIX), Caterpillar Inc. (CAT)

Northern Trust Corporation (NTRS) retreated with the stock falling -4.72% or $-4.16 to close at $83.99 on active trading volume of 3.43M compared its three months average trading volume of 1.41M. The Chicago Illinois 60603 based company operating under the Asset Management industry has been trending up for the last 52 weeks, with the shares price now 34.13% up for the period and down by -5.68% so far this year. With price target of $89.81 and a 57.68% rebound from 52-week low, Northern Trust Corporation has plenty of upside potential, making it a hold with a view buy.

Northern Trust Corporation, a financial holding company, provides asset servicing, fund administration, asset management, fiduciary, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates through two segments, Corporate & Institutional Services (C&IS) and Wealth Management. The C&IS segment offers asset servicing and related services, including global custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment provides services to corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic services; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately-held businesses. The company also provides asset management services, such as active, passive, and engineered equity; active and passive fixed income; cash management; alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay services and other risk management services. Northern Trust Corporation was founded in 1889 and is based in Chicago, Illinois.

Neurocrine Biosciences, Inc. (NBIX) had a active trading with around 3.43M shares changing hands compared to its three month average trading volume of 1.07M. The stock traded between $38.84 and $43.44 before closing at the price of $42.04 with 4.66% change on the day. The San Diego California 92130 based company is currently trading 34.53% above its 52 week low of $31.25 and -23.77% below its 52 week high of $55.15. Both the RSI indicator and target price of  and $68 respectively, lead us to believe that it could rise over the coming weeks.

Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company’s products in clinical development stage include elagolix, which is in Phase III study for endometriosis and uterine fibroids; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2) that is in Phase III study for tardive dyskinesia, as well as in Phase II study for tourette syndrome; and NBI-640756, which is in Phase I study for essential tremor. Its research programs comprise Corticotropin-Releasing Factor Receptor1 Antagonist for congenital adrenal hyperplasia; VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, and other Indications. It has collaborations with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women’s and men’s health; Mitsubishi Tanabe Pharma Corporation to develop and commercialize valbenazine for movement disorders in Japan and other Asian markets; The Mount Sinai School of Medicine of the City University of New York to develop and commercialize licensed products worldwide; and Dainippon Sumitomo Pharma Co. Ltd. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.

Caterpillar Inc. (CAT) saw its value decrease by -0.26% as the stock dropped $-0.24 to finish the day at a closing price of $93.33. The stock was lighter in trading and has fluctuated between $57.46-$97.4 per share for the past year. The shares, which traded within a range of $92.53 to $93.42 during the day, are up by 7.86% in the past three months and up by 18.08% over the past six months. It is currently trading -0.29% below its 20 day moving average and 0.11% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $88.25 a share over the next twelve months. The current relative strength index (RSI) reading is 47.87.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. The company’s Construction Industries segment offers backhoe, small wheel, skid steer, multi-terrain, compact track, medium and compact wheel, and track-type loaders; mini, wheel, and track excavators; track-type tractors; and select work tools, motor graders, telehandlers, soil compactors, and pipelayers, as well as its related parts for the heavy and general construction, rental, mining and quarry, and aggregates markets. Its Resource Industries segment provides electric rope and hydraulic shovels; draglines; drills; highwall and longwall miners; hard rock vehicles; articulated, large mining, and off-highway trucks; large wheel loaders; wheel tractor scrapers; wheel dozers; machinery components; hard rock continuous mining systems; electronics and control systems; and select work tools for use in mining and quarry applications. The company’s Energy & Transportation segment offers reciprocating engines, generator sets, marine propulsion systems, gas turbines and turbine-related services, diesel-electric locomotives, and other rail-related products and services. Its Financial Products segment provides retail and wholesale financing for Caterpillar equipment, machinery, and engines; offers property, casualty, life, accident, and health insurance; insurance brokerage services; and purchases short-term trade receivables. The company’s All Other segments remanufactures Cat engines and components, and provides remanufacturing services for other companies; offers business strategy, and development, management, manufacturing, marketing, and support primarily for paving, forestry, industrial, waste, and Cat products. The company was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar Inc. in 1986. The company was founded in 1925 and is headquartered in Peoria, Illinois.

 

Three Movers to Watch for: Pfizer Inc. (PFE), JPMorgan Chase & Co. (JPM), Wells Fargo & Company (WFC)

Pfizer Inc. (PFE) retreated with the stock falling -0.09% or $-0.03 to close at $32.03 on light trading volume of 21.45M compared its three months average trading volume of 27.21M. The New York New York 10017 based company operating under the Drug Manufacturers – Major industry has been trending up for the last 52 weeks, with the shares price now 8.31% up for the period and down by -1.39% so far this year. With price target of $37.65 and a 16.5% rebound from 52-week low, Pfizer Inc. has plenty of upside potential, making it a hold with a view buy.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, and Transgene S.A.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh; and a strategic collaboration agreement with IGNITE Immunotherapy Inc. It also has a collaboration with AbCellera Biologics Inc. to discover therapeutic antibodies against undisclosed membrane protein targets. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

JPMorgan Chase & Co. (JPM) gained $0.39 to close the day at a new closing price of $83.94, a 0.47% increase in value from its previous closing price that moved the stock 64.41% above its 52 week low of $52.5. A total of 21.21M shares exchanged hands during the day compared with its three month average trading volume of 17.87M. The stock, which fluctuated between $83.03 and $84.23 during the day, currently situated -4.8% below its 52 week high. The stock is down by -1.86% in the past one month and up by 25.66% over the past three months. With a one year target estimate of $87.59 and RSI of 46.04, the stock still has upside potential, making it a hold for now.

JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset Management segments. The Consumer & Community Banking segment offers deposit and investment products and services to consumers; lending, deposit, and cash management and payment solutions to small businesses; residential mortgages and home equity loans; and credit cards, payment services, payment processing services, auto loans and leases, and student loans. The Corporate & Investment Bank segment provides investment banking products and services, including advising on corporate strategy and structure, capital-raising in equity and debt markets, as well as loan origination and syndication; treasury services, such as cash management and liquidity solutions; and cash securities and derivative instruments, risk management solutions, prime brokerage, and research services. It also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The Commercial Banking segment offers financial solutions, including lending, treasury, investment banking, and asset management to corporations, municipalities, financial institutions, and nonprofit entities, as well as financing to real estate investors and owners. The Asset Management segment provides investment and wealth management services across various asset classes, such as equities, fixed income, alternatives, and money market funds; multi-asset investment management services; retirement services; and brokerage and banking services comprising trusts, estates, loans, mortgages, and deposits. It has a strategic relationship with InvestCloud for the development of new digital capabilities for individual investors. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.

Wells Fargo & Company (WFC) shares were up in last trading by 0.91% to $54.27. It experienced lighter than average volume on day. The stock decreased in value by almost -0.64% over the past week and fell -1.67% in the past month. It is currently trading 1.39% above its 50 day moving average and 11.3% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -6.46% decrease in value from its one year high of $58.02. The RSI indicator value of 47.32, lead us to believe that it is a hold for now.

Wells Fargo & Company provides retail, commercial, and corporate banking services to individuals, businesses, and institutions. Its Community Banking segment offers checking, savings, market rate, individual retirement, and health savings accounts, as well as time deposits and remittances; and lines of credit, auto floor plan lines, equity lines and loans, equipment and transportation loans, education and residential mortgage loans, and debit and credit cards. This segment also provides equipment leases, real estate and other commercial financing, small business administration financing, venture capital financing, cash management, payroll services, retirement plans, and merchant payment processing and private label financing solutions, as well as purchases retail installment contracts. Its Wholesale Banking segment offers commercial loans and lines of credit, letters of credit, asset-based lending, equipment leasing, international trade facilities, trade financing, collection, foreign exchange, treasury management, investment management, institutional fixed-income sales, interest rate, commodity and equity risk management, insurance, corporate trust fiduciary and agency, and investment banking services, as well as online/electronic products. This segment also provides construction, and land acquisition and development loans; secured and unsecured lines of credit; interim financing arrangements; rehabilitation loans; affordable housing loans and letters of credit; loans for securitization; commercial real estate loan servicing; and real estate and mortgage brokerage services. The company’s Wealth, Brokerage and Retirement segment offers financial advisory, wealth management, brokerage, retirement, trust, and reinsurance services. As of February 25, 2015, it operated through approximately 8,700 locations and 12,500 ATMs & offices in 36 countries. Wells Fargo & Company was founded in 1852 and is headquartered in San Francisco, California.

 

Three Movers to Watch for: Boston Scientific Corporation (BSX), Office Depot, Inc. (ODP), Southwest Airlines Co. (LUV)

Boston Scientific Corporation (BSX) grew with the stock adding 0.08% or $0.02 to close at $23.92 on light trading volume of 5.93M compared its three months average trading volume of 8.87M. The Marlborough Massachusetts 01752 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 36.14% up for the period and up by 10.59% so far this year. With price target of $27.55 and a 52.65% rebound from 52-week low, Boston Scientific Corporation has plenty of upside potential, making it a hold with a view buy.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Office Depot, Inc. (ODP) dropped $-0.16 to close the day at a new closing price of $4.54, a -3.4% decrease in value from its previous closing price that moved the stock 51.65% above its 52 week low of $3.01. A total of 5.91M shares exchanged hands during the day compared with its three month average trading volume of 7.84M. The stock, which fluctuated between $4.5 and $4.74 during the day, currently situated -41.88% below its 52 week high. The stock is down by -5.42% in the past one month and up by 40.02% over the past three months. With a one year target estimate of $4.99 and RSI of 45.43, the stock still has upside potential, making it a hold for now.

Office Depot, Inc., together with its subsidiaries, supplies office products and services. It operates in three segments: North American Retail, North American Business Solutions, and International. The company sells office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture. It also offers copy and print services. The company sells its products and services to consumers and businesses through office supply stores, a contract sales force, Internet sites, an outbound telephone account management sales force, direct marketing catalogs, and call centers, as well as participates under licensing and merchandise arrangements in Latin America, Europe, Israel, and Japan. As of December 26, 2015, it operated 1,564 stores in the United States, including Puerto Rico and the U.S. Virgin Islands; and 147 stores in France, South Korea, Sweden, New Zealand, and Australia. The company offers its products under various labels, including Office Depot, OfficeMax, Foray, Ativa, TUL, Realspace, WorkPro, Brenton Studio, Highmark, Grand & Toy, and Viking Office Products. Office Depot, Inc. was founded in 1986 and is headquartered in Boca Raton, Florida.

Southwest Airlines Co. (LUV) shares were up in last trading by 0.28% to $50.38. It experienced lighter than average volume on day. The stock decreased in value by almost -1.87% over the past week and fell -0.42% in the past month. It is currently trading 4.89% above its 50 day moving average and 19.54% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -3.49% decrease in value from its one year high of $52.2. The RSI indicator value of 53.6, lead us to believe that it is a hold for now.

Southwest Airlines Co. operates passenger airlines that provide scheduled air transportation services in the United States and near-international markets. As of December 31, 2015, it operated 704 Boeing 737 aircraft. The company served 97 destinations in 40 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as 7 near-international countries, including Mexico, Jamaica, The Bahamas, Aruba, the Dominican Republic, Costa Rica, and Belize. It also sells frequent flyer points and related services to business partners participating in the Rapid Rewards frequent flyer program, including car rental agencies, hotels, restaurants, and retailers. The company was founded in 1967 and is headquartered in Dallas, Texas.

 

Eye Catching Stocks: Johnson Controls International plc (JCI), Cognizant Technology Solutions Corporation (CTSH), salesforce.com, inc. (CRM)

Johnson Controls International plc (JCI) continued its downward trend with the stock declining -0.05% or $-0.02 to close the day at $43.09 on light trading volume of 4M shares, compared to its three month average trading volume of 6.03M. The Cork Cork T12 X8N6 based company has been outperforming the auto parts group over the past 52 weeks, with the stock gaining 45.19%, compared to the industry which has advanced 32.38% over the same period. With RSI of 50.28, the stock should still continue to rise and get closer to its one year target estimate of $50.18, making it a hold for now.

Johnson Controls International plc operates as a diversified technology and multi industrial company worldwide. The company operates through Buildings and Power Solutions segments. It designs, produces, markets, and installs heating, ventilating, and air conditioning (HVAC) systems, building management systems, controls, and security and mechanical equipment. The company also provides residential air conditioning and heating systems, and industrial refrigeration products, as well as technical and energy management consulting services. In addition, it designs, sells, installs, services, and monitors electronic security systems, and fire detection and suppression systems; and manufactures and sells intrusion security products, anti-theft devices, breathing apparatus, and access control and video management systems for commercial, industrial, retail, residential, small business, institutional, and governmental customers. Further, the company produces and supplies lead-acid automotive batteries for passenger cars, light trucks, and utility vehicles, as well as advanced battery technologies to power start-stop, hybrid, and electric vehicles. It offers its lead-acid automotive batteries to automotive original equipment manufacturers and the general vehicle battery aftermarket. The company was formerly known as Johnson Controls, Inc. and changed its name to Johnson Controls International plc in September 2016. Johnson Controls International plc was founded in 1885 and is headquartered in Cork, Ireland.

Cognizant Technology Solutions Corporation (CTSH) climbed 1.38% during last trading as the stock added $0.78 to finish the day at $57.36 with about 3.97M shares changing hands, compared to its three month average trading volume of 6.26M. The $35.09B market cap company, which fluctuated between $56.6 and $57.63 during the day, currently situated 26.23% above its 52 week low of $45.44 and -9.57% away from its one year high of $63.43. The RSI of 56.11 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process services worldwide. The company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. Its consulting and technology services include IT strategy consulting, program management consulting, operations improvement consulting, strategy consulting, and business consulting services; and application design and development, systems integration, enterprise resource planning, and customer relationship management implementation services. The company also offers enterprise information management services, such as strategic, advisory, and management consulting; enterprise data management; descriptive analytics/business intelligence; strategic corporate performance management; and packaged analytics services, as well as big data services that assist clients in managing and deriving actionable insights. In addition, it provides application testing services; and develops, licenses, implements, and supports proprietary and third-party software products, as well as offers digital technologies services. Further, the company offers outsourcing services, such as application maintenance services; IT infrastructure services; and business process services, including clinical data management, pharmacovigilance, equity research support, commercial operations, and order management. It serves various industries, including banking and insurance; healthcare and life sciences; manufacturing and logistics; retail, travel, and hospitality; consumer goods; communications; information, media, and entertainment; and technology. The company markets and sells services through its professional staff, senior management, and direct sales personnel. Cognizant Technology Solutions Corporation was founded in 1998 and is headquartered in Teaneck, New Jersey.

salesforce.com, inc. (CRM) saw its value increase by 1.01% as the stock gained $0.76 to finish the day at a closing price of $75.78. The stock was lighter in trading and has fluctuated between $52.6-$84.48 per share for the past year. The shares, which traded within a range of $75.08 to $76.22 during the day, are up by 4.05% in the past three months and down by -6.87% over the past six months. It is currently trading 5.6% above its 20 day moving average and 4.45% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $94.44 a share over the next twelve months. The current relative strength index (RSI) reading is 64.92. The technical indicator lead us to believe there will be no major movement any time soon, hold.

salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. Further, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. The company has a strategic alliance with Cisco to develop IoT and contact center platforms. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.

 

Stock’s Trend Analysis Report: Nordstrom, Inc. (JWN), Cypress Semiconductor Corporation (CY), Arena Pharmaceuticals, Inc. (ARNA)

Nordstrom, Inc. (JWN) fell -0.16% during last trading as the stock lost $-0.07 to finish the day at $44.31 with about 3.71M shares changing hands, compared to its three month average trading volume of 3.45M. The $7.83B market cap company, which fluctuated between $42.9 and $45.22 during the day, currently situated 28.29% above its 52 week low of $35.01 and -29.01% away from its one year high of $62.82. The RSI of 27.31 indicates the stock is oversold at the current levels, buy for now.

Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for men, women, and children in the United States and Canada. It operates through two segments, Retail and Credit. The Retail segment offers a selection of brand name and private label merchandise through various channels, including Nordstrom branded full-line stores and online store at Nordstrom.com; Nordstrom Rack stores; Nordstromrack.com and HauteLook; and other retail channels, including Trunk Club showrooms and TrunkClub.com, Jeffrey boutiques, and clearance store that operates under the name Last Chance. The Credit segment operates Nordstrom fsb, a federal savings bank, which provides a private label credit card, two Nordstrom VISA credit cards, and a debit card. Its credit and debit cards feature a shopping-based loyalty program. As of January 12, 2017, the company operated 349 stores in 40 states, including 123 full-line stores in the United States, Canada, and Puerto Rico; 215 Nordstrom Rack stores; 2 Jeffrey boutiques; and 2 clearance stores. Nordstrom, Inc. also sells its products through catalogs. The company was founded in 1901 and is based in Seattle, Washington.

Cypress Semiconductor Corporation (CY) dropped $-0.05 to close the day at a new closing price of $11.38, a -0.44% decrease in value from its previous closing price that moved the stock 88.74% above its 52 week low of $6.3. A total of 3.7M shares exchanged hands during the day compared with its three month average trading volume of 5.08M. The stock, which fluctuated between $11.34 and $11.52 during the day, currently situated -7.07% below its 52 week high. The stock is up by 3.59% in the past one month and up by 7.06% over the past three months. With a one year target estimate of $13.45 and RSI of 51.58, the stock still has upside potential, making it a hold for now.

Cypress Semiconductor Corporation designs, develops, manufactures, markets, and sells mixed-signal programmable solutions worldwide. The company’s Programmable Solutions division designs and develops programmable solutions, including Traveo automotive microcontrollers; programmable system-on-chip products; ARM Cortex-M4, -M3, and -M0+ microcontrollers; R4 CPUs; analog power management integrated circuits; CapSense capacitive-sensing controllers; TrueTouch touchscreen and fingerprint reader products; and Bluetooth low energy solutions for the Internet of things. Its Memory Products division designs and manufactures NOR and NAND flash memories, static random access memory (SRAM) products, HyperRAm, synchronous and asynchronous SRAMs, nvSRAMs, F-RAM ferroelectric memory devices, dual port memories, first-in first-out memories, RoboClock buffers, and programmable clocks. The company’s Data Communications division provides universal serial bus (USB) controllers; Bluetooth low energy and wirelessUSB solutions; module solutions, such as trackpads and Bluetooth low energy modules; and controllers for the new USB type-C standards. Its Emerging Technology division provides wafer level chip scale packaging solutions and foundry services, as well as other development stage activities. The company serves various markets, including automotive, industrial, communications, consumer, computation, data communications, mobile handsets, and military markets. It sells its semiconductor products through distributors and manufacturing representative firms, as well as through sales force to direct original equipment manufacturers and their suppliers. The company has a strategic foundry partnership with HuaHong Grace Semiconductor Manufacturing Corporation and United Microelectronics Corporation. Cypress Semiconductor Corporation was founded in 1982 and is headquartered in San Jose, California.

Arena Pharmaceuticals, Inc. (ARNA) had a active trading with around 3.66M shares changing hands compared to its three month average trading volume of 1.58M. The stock traded between $1.35 and $1.4 before closing at the price of $1.37 with -0.72% change on the day. The San Diego California 92121 based company is currently trading 3.79% above its 52 week low of $1.32 and -36.57% below its 52 week high of $2.16. Both the RSI indicator and target price of 39.38 and $3.75 respectively, lead us to believe that it should be put on hold over the coming weeks.

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors to address unmet medical needs in the United States and South Korea. The company offers BELVIQ, a drug used to treat chronic weight management in adults. It is also developing a portfolio of programs in various therapeutic areas, including cardiovascular, central nervous system, and metabolic diseases. Its products under development include APD334, a modulator of the sphingosine 1-phosphate subtype 1 receptor for the treatment of a various autoimmune diseases, which is in Phase II clinical trials; and Ralinepag that is in Phase II clinical trials for the treatment of pulmonary arterial hypertension. The company’s products under development also comprise APD371, an agonist of the cannabinoid-2 receptor that is in Phase I clinical trials for the treatment of pain; Nelotanserin, which is in Phase II clinical trials for the treatment of dementia-associated psychosis; Temanogrel, which is in Phase I clinical trials for thrombotic diseases; and Undisclosed Orphan GPCR that is in pre-clinical development for central nervous system indications. In addition, it manufactures drug products under a toll manufacturing agreement for Siegfried AG. Arena Pharmaceuticals, Inc. has collaboration with Boehringer Ingelheim International GmbH. The company was founded in 1997 and is based in San Diego, California.